This is a 12-month, 3-arm randomized controlled trial of 315 Childhood Cancer Survivor
Study (CCSS) survivors using a text message intervention with data collected at baseline
and 12 months through patient and provider surveys and interviews and a medical record
review. Participants will be randomly assigned to one of three groups: control, patient
activation (PA) using a text message/video intervention, or patient activation + primary
care provider activation (PA + PCP) which will include providing primary care providers
with resources about colorectal cancer risk in this population. All participants will
receive electronic resources about their previous cancer treatment and colorectal cancer
screening recommendations.
The primary outcome is the proportion of patients who complete the colonoscopy or
Cologuard test (Cologuard test plus colonoscopy if the Cologuard is positive) within 12
months of enrolling on the study, as measured via self-report questions in the end of
study questionnaire. The study will test the hypothesis that, compared to controls,
survivors randomized to the PA and PA + PCP activation groups will have significantly
higher rates of completion of colorectal cancer screening.
